Search Medical Condition
Please enter condition
Please choose location from dropdown

Reus, Spain Clinical Trials

A listing of Reus, Spain clinical trials actively recruiting patients volunteers.

Found (64) clinical trials

Thoracic Tumours Register

In Europe, patients with lung cancer have a poor prognosis, and there has been only limited improvement between 1999 and 2007. Potential advantages of the centralization of care and the discussion of treatment strategies in multidisciplinary teams, as suggested in other studies,13 require further research. However, the priorities should be …

Phase N/A

2.08 miles

Learn More »

Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection

Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile Infection (CDI) with the goal of achieving comparable cure rates to standard of care, but reducing rates of recurrent disease. A phase 2 proof of concept study, with vancomycin as comparator, demonstrated these attributes with a comparable safety profile. …

Phase

2.08 miles

Learn More »

Effect of Hybrid Laser 10600+1540 nm on GSM

The primary objective of the study is to clinically confirm, by comparison with a control group, the performance of the 10600 +1540 nm laser in the improvement of atrophic vaginal epithelium at 3 months after the last laser treatment. The secondary objectives are: Confirm the performance of 10600 +1540 nm …

Phase N/A

2.08 miles

Learn More »

Second-line FOLFIRI + Panitumumab in Subjects With Wild Type RAS Metastatic Colorectal

A phase II, multicentre, open-label, randomized two-arm study. Subjects treated in first-line with panitumumab and FOLFOX and with wild type RAS mCRC confirmed in liquid biopsies before starting second line treatment will be screened for this trial. Only subjects who have interrupted panitumumab for < 3 months (panitumumab continuation) will …

Phase

2.08 miles

Learn More »

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Subject enrolment may proceed with information available on tumor HRAS status previously generated during the pre-screening phase, but all subjects must consent to provide tumor slides (or tumor tissue block) from a prior diagnostic biopsy for a retrospective testing of RAS gene status, including T81C polymorphism, and other potential biomarkers …

Phase

2.08 miles

Learn More »

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

Study design: This is a prospective multicenter study in 2 phases: Exploratory phase. It will include 10 patients, to assess the feasibility and efficacy of low-dose lung irradiation. If a minimum efficiency of 30% is not achieved, the study will not be continued. Comparative phase in two groups, a control …

Phase N/A

2.08 miles

Learn More »

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2 Breast Cancer

Phase III, double-blind, randomised study assessing the efficacy of capivasertib + fulvestrant vs placebo + fulvestrant for the treatment of patients with locally advanced (inoperable) or metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2) breast cancer following recurrence or progression on or after aromatase inhibitor (AI) …

Phase

2.08 miles

Learn More »

LunG canceR pAtients coVId19 Disease (GRAVID)

This is a multi-centre study on lung cancer patients which experienced COVID-19. Information on clinical features, clinical course, management and outcomes will be collected for both, thoracic cancers and COVID-19 infection. Firstly, investigators will be registered in an online secure registry. After that, a protocol will be developed in order …

Phase N/A

2.08 miles

Learn More »

A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis Na ve to Biological Treatment

Observational, prospective and multicenter study in approximately 25 sites nationwide. The investigators participating in this study will be rheumatologists specializing in this pathology. The study will include patients diagnosed with PsA (according to the CASPAR diagnosis criteria), nave to biological treatments, who have - following the routine practice in their …

Phase N/A

7.29 miles

Learn More »

ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO

A chronic total occlusion (CTO) is observed in up to (1) 30 % of patients undergoing diagnostic coronary angiography. The presence of a CTO is associated with worse outcome compared to non-occlusive coronary artery disease. Percutaneous Coronary Intervention (PCI) treatment of CTO lesions has gained much attention over the last …

Phase N/A

7.29 miles

Learn More »